Human Trisome Project
Additional information about this study can be found at www.trisome.org....
Protocol #: 15-2170
Location: Childrens Hospital Colorado, Outpatient CTRC, Outpatient CTRC, University of Colorado Hospital
|
CU Faces of Hope-Genetics of Craniofacial and Dental Development Research Study
This study plans to collect samples to create a database of patients with various syndromes that affect the way bones of the face are formed, termed “craniofacial”. These samples will support a new research program, named CU Faces of Hope, which involves a team of researchers and doctors ...
Protocol #: 18-1916
Location: Childrens Hospital Colorado
|
Safety and efficacy of tofacitinib for immune skin conditions in Down syndrome
This study is designed to determine whether tofacitinib is a safe and effective treatment for immune skin conditions in adults with Down syndrome, and to further our understanding of the immune system in Down syndrome.
This is a single arm, open-label study. All participants will receiv...
Protocol #: 19-1362
Location: Outpatient CTRC, Outpatient CTRC, University of Colorado Hospital
|
Executive Functioning Outcome Measures for Down Syndrome
Protocol #: 19-2576
Location: Childrens Hospital Colorado
|
A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (IND#:133494, NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
Protocol #: 19-2631
Location: Childrens Hospital Colorado
|
A Pivotal Phase 3 Study of FCX-007 (Genetically-Modified Autologous Human Dermal Fibroblasts) for Recessive Dystrophic Epidermolysis Bullosa (DEFI-RDEB)
Protocol #: 19-1972
Location: Childrens Hospital Colorado
|
ACcomplisH: A Phase 2, multicenter, double-blind, randomized, placebo-controlled, dose escalation trial evaluating safety, efficacy, and pharmacokinetics of subcutaneous doses of TransCon CNP administered once weekly for 12 months in prepubertal children with achondroplasia
Protocol #: 20-0142
Location: Childrens Hospital Colorado
|
Role of Kv7 channels in the regulation of placental arteries vasoreactivity in mothers with Long QT syndrome (LQTS) Types 1 and 2
Protocol #: 20-0226
Location: Childrens Hospital Colorado, Memorial Hospital Central, University of Colorado Hospital
|
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecerfont (NBI-74788) in Adult Subjects with Classic Congenital Adrenal Hyperplasia, Followed by Open-Label Treatment
Protocol #: 20-2113
Location: Childrens Hospital Colorado
|
MicroRNA as a Maternal and Neonatal Biomarker to Predict Congenital Diaphragmatic Hernia Severity
Protocol #: 21-2481
Location: Childrens Hospital Colorado, University of Colorado Hospital
|
Multicentric Carpotarsal Osteolysis (MCTO): Natural History Study
Protocol #: 21-2606
Location: Childrens Hospital Colorado
|
Identifying novel therapeutic targets in MCTO by unbiased proteomics of patient plasma
Protocol #: 21-3367
Location: Childrens Hospital Colorado, Department Specific Free Standing Clinic
|
